Sodium-dependent glucose transporter 2 (SGLT-2) inhibitors, a new type of drug for the treatment of diabetes, are widely found in the kidneys and reabsorbs glucose through the glomeruli [9]. The gene discussed is SLC5A2; the disease is diabetes mellitus.